Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 29, 1994 - Issue sup204
Submit an article Journal homepage
26
Views
33
CrossRef citations to date
0
Altmetric
Original Article

Ursodeoxycholic Acid Therapy in Treatment of Primary Sclerosing Cholangitis

A. Stiehl Dept. of Medicine, University of Heidelberg, Heidelberg, Germany
Pages 59-61 | Published online: 08 Jul 2009

Citations (33)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Arun Jeevagan. (2010) Overlap of primary biliary cirrhosis and primary sclerosing cholangitis – a rare coincidence or a new syndrome. International Journal of General Medicine 3, pages 143-146.
Read now

Articles from other publishers (32)

Kris V. Kowdley, Lisa Forman, Bertus Eksteen, Nadege Gunn, Vinay Sundaram, Charles Landis, Stephen A. Harrison, Cynthia Levy, Alexander Liberman, Adrian M. Di Bisceglie & Gideon M. Hirschfield. (2022) A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis. American Journal of Gastroenterology 117:11, pages 1805-1815.
Crossref
Supratim Choudhuri & Curtis D. Klaassen. (2022) Molecular Regulation of Bile Acid Homeostasis. Drug Metabolism and Disposition 50:4, pages 425-455.
Crossref
Fernando Bessone, Nelia Hernández, Mario Tanno & Marcelo G. Roma. (2021) Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics. Seminars in Liver Disease 41:03, pages 331-348.
Crossref
Nathalie Pena Polanco, Claudia Cottone & Kalyan Ram Bhamidimarri. (2020) PSC and Overlap Syndromes. Current Hepatology Reports 19:2, pages 106-118.
Crossref
Alyssa Kriegermeier & Richard Green. (2020) Pediatric Cholestatic Liver Disease: Review of Bile Acid Metabolism and Discussion of Current and Emerging Therapies. Frontiers in Medicine 7.
Crossref
Vik Meadows, Lindsey Kennedy, Debjyoti Kundu, Gianfranco Alpini & Heather Francis. (2020) Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases. Frontiers in Medicine 7.
Crossref
Francesca Saffioti, Kurinchi Selvan Gurusamy, Neil Hawkins, Clare D Toon, Emmanuel Tsochatzis, Brian R Davidson & Douglas Thorburn. (2017) Pharmacological interventions for primary sclerosing cholangitis. Cochrane Database of Systematic Reviews 2017:4.
Crossref
Irene Franceschet, Nora Cazzagon, Teresa Del Ross, Renata D’Incà, Alessandra Buja & Annarosa Floreani. (2016) Primary sclerosing cholangitis associated with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 28:5, pages 508-513.
Crossref
Nirav Thosani & Subhas Banerjee. (2014) Endoscopic Retrograde Cholangiopancreatography for Primary Sclerosing Cholangitis. Clinics in Liver Disease 18:4, pages 899-911.
Crossref
Said Al Mamari, Jelena Djordjevic, John S. Halliday & Roger W. Chapman. (2013) Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis. Journal of Hepatology 58:2, pages 329-334.
Crossref
E. L. Culver & R. W. Chapman. (2011) Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 33:12, pages 1273-1291.
Crossref
Sammy Al-Benna, Jörg Willert, Hans-Ulrich Steinau & Lars Steinstraesser. (2011) Aetiopathology and management of secondary sclerosing cholangitis following burn injury. Burns 37:2, pages 356-359.
Crossref
Lucas Maillette de Buy Wenniger & Ulrich Beuers. (2010) Bile salts and cholestasis. Digestive and Liver Disease 42:6, pages 409-418.
Crossref
Roger Chapman, Johan Fevery, Anthony Kalloo, David M. Nagorney, Kirsten Muri Boberg, Benjamin Shneider & Gregory J. Gores. (2010) Diagnosis and management of primary sclerosing cholangitis. Hepatology 51:2, pages 660-678.
Crossref
Dirk R. de Waart & Ronald P. J. Oude Elferink. 2009. Transporters as Drug Carriers. Transporters as Drug Carriers 299 324 .
. (2009) EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. Journal of Hepatology 51:2, pages 237-267.
Crossref
Maria J Perez & Oscar Briz. (2009) Bile-acid-induced cell injury and protection. World Journal of Gastroenterology 15:14, pages 1677.
Crossref
B. van Hoek, C.M.J. van Nieuwkerk & S.V. Jarbandhan. 2009. Leverziekten. Leverziekten 108 118 .
Ulrich Beuers. 2007. Textbook of Hepatology. Textbook of Hepatology 1120 1126 .
Ulrich Beuers & Christian Rust. 2007. Liver Immunology. Liver Immunology 285 291 .
Robert Enns. 2006. Diseases of the Gallbladder and Bile Ducts. Diseases of the Gallbladder and Bile Ducts 306 331 .
Katja S Rothfuss, Eduard F Stange & Klaus R Herrlinger. (2006) Extraintestinal manifestations and complications in inflammatory bowel diseases. World Journal of Gastroenterology 12:30, pages 4819.
Crossref
Thomas Pusl. (2006) Ursodeoxycholic acid treatment of vanishing bile duct syndromes. World Journal of Gastroenterology 12:22, pages 3487.
Crossref
Ulrich Beuers. (2005) Hepatic overlap syndromes. Journal of Hepatology 42:1, pages S93-S99.
Crossref
Pratima Sharma & Jorge Rakela. (2005) Management of pre-liver transplantation patients?Part 1. Liver Transplantation 11:2, pages 124-133.
Crossref
Jayant A. Talwalkar & Keith D. Lindor. (2005) Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases 11:1, pages 62-72.
Crossref
W. Hempfling, K. Dilger & U. Beuers. (2003) Ursodeoxycholic acid - adverse effects and drug interactions. Alimentary Pharmacology & Therapeutics 18:10, pages 963-972.
Crossref
Peter N. Meier & Michael P. Manns. (2001) Medical and endoscopic treatment in primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 15:4, pages 657-666.
Crossref
Florencia G. Que, Vy A. Phan, Van H. Phan, Nicholas F. LaRusso & Gregory J. Gores. (1999) GUDC Inhibits CytochromecRelease from Human Cholangiocyte Mitochondria. Journal of Surgical Research 83:2, pages 100-105.
Crossref
N Assy. (1999) Diagnostic approach to patients with cholestatic jaundice. World Journal of Gastroenterology 5:3, pages 252.
Crossref
Eduardo Luiz R Cançado, Regina Maria Cubero Leitão, Flair José Carrilho & Antônio Atílio Laudanna. (1998) Unexpected Clinical Remission of Cholestasis After Rifampicin Therapy in Patients With Normal or Slightly Increased Levels of Γ-Glutamyl Transpeptidase. American Journal of Gastroenterology 93:9, pages 1510-1517.
Crossref
Adolf Stiehl, Gerda Rudolph, Peter Sauer, Christine Benz, Wolfgang Stremmel, Siegfried Walker & Lorenz Theilmann. (1997) Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. Journal of Hepatology 26:3, pages 560-566.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.